Aside from the potential curse of long COVID, people who've had the SARS-CoV-2 virus may be more likely to develop high ...

Annovis Bio has commenced the treatment of first two subjects in a randomised Phase III clinical trial to assess the efficacy and safety of buntanetap in treating early Alzheimer's disease (AD). The ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

Rainwater Prizes honor researchers worldwide who are advancing discoveries for diseases caused by tau protein accumulations ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

Scientists have discovered a potential new drug that could help people with Alzheimer’s disease by improving memory and ...

There is no cure. Between 1995 and 2021, around $42bn was poured into more than 1,000 clinical trials. Yet only a handful of ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Delayed REM sleep may be linked to a higher risk of Alzheimer’s disease, new research found. Here's how to build a healthy sleep routine.

(HealthDay News) — Average life expectancy for patients with dementia ranges from 8.9 years after diagnosis at a mean age of 60 years for women to 2.2 years at a mean age of 85 years for men, ...